By Annette Pinder
Dr. Thomas Guttuso’s long covid study is going extremely well, and he is now looking for just seven more people between the ages of 18 to 80 who are suffering from long COVID symptoms.
This is the perfect opportunity to join the 90% of people in the study who have reported improvements in their long COVID symptoms without any side-effects. Patients are reporting improvements within four days. The study is double-blind, which means that some patients receive the treatment, and others receive an inactive placebo. However, after 21 days, all patients can receive the treatment. The study has been so successful that area physicians have been sending their patients with long COVID symptoms to Dr. Guttuso for treatment.
The treatment of an extremely small doze of lithium (the equivalent of taking a daily dose of calcium or magnesium). The clinical trial is funded by UB’s Clinical and Translational Science Institute. Anyone with long COVID symptoms can also participate in UB’s Long COVID registry. Call 716-829-5454 for information.
